Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "The charts are saying that Sun Pharmaceutical after that big decline is stabilising. So, on dips and on say on any kind of market reaction on the downside, I would be a buyer in the stock."At 09:57 hrs Sun Pharmaceutical Industries was quoting at Rs 738.65, down Rs 51.80, or 6.55 percent.The share touched its 52-week high Rs 1,200.70 and 52-week low Rs 706.40 on 07 April, 2015 and 24 November, 2015, respectively.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!